NIH PAR · NHLBI · K22

PAR-24-211: NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22 Clinical Trial Required)

Reviewed by Dr. Meng ZhaoLast reviewed October 16, 2026Data refreshed October 16, 2026Editorial standards

Open for applicationsExpires Jul 13, 2027

The purpose of the NHLBI Career Transition Award (K22) program is to provide highly qualified postdoctoral fellows in the NHLBI Division of Intramural Research the opportunity to transition their research programs as new investigators to extramural institutions. To achieve these objectives, the NHLBI Career Transition Award will support two phases of research: a mentored intramural phase (up to two years) and an extramural phase (three years), for a total of five years of combined support. Transition from the intramural phase of support to the extramural phase is not automatic. Approval of the transition will be based on the success of the awardee's research program during the mentored…

Full NOFO in the NIH Guide Apply on Grants.gov

NOFO number
PAR-24-211
Type
PAR
Activity code
K22
Primary institute
NHLBI · National Heart, Lung, and Blood Institute
Clinical trials
Required
Posted
Jul 15, 2024
Opens
Sep 12, 2024
Expires
Jul 13, 2027

PAR-24-211 due dates

No application due dates remain in the listed cycles. Dates marked * are NIH standard due dates. Check the related notices below for changes NIH made after posting.

Application due dates and review cycles for PAR-24-211
Letter of Intent Due Date(s)
Not Applicable
October 12, 2024
November 12, 2024 *
Not Applicable
March 2025
May 2025
July 2025
February 12, 2025
March 12, 2025 *
Not Applicable
July 2025
October 2025
December 2025
June 12, 2025
July 12, 2025 *
Not Applicable
November 2025
January 2026
April 2026
October 12, 2025
November 12, 2025 *
Not Applicable
March 2026
May 2026

Funded projects

NIH RePORTER lists no awards under PAR-24-211 in FY2022–FY2026. Awards usually appear a few months after the first review cycle.

Participating institutes

2 NIH institutes and offices take applications under PAR-24-211. Contact the program officer at the institute that fits your research before applying.

  • NHLBI · National Heart, Lung, and Blood Institute
  • none

Related notices

  1. Mar 31, 2025

    This funding opportunity was updated to align with agency priorities. Carefully reread the full funding opportunity and make any needed adjustments to your application prior to submission.

  2. Apr 4, 2024 · NOT-OD-24-084

    Overview of Grant Application and Review Changes for Due Dates on or after January 25, 2025.

  3. Aug 31, 2022 · NOT-OD-22-198

    Implementation Changes for Genomic Data Sharing Plans Included with Applications Due on or after January 25, 2023. See Notice NOT-OD-22-198.

  4. Aug 5, 2022 · NOT-OD-22-189

    Implementation Details for the NIH Data Management and Sharing Policy. See Notice NOT-OD-22-189.

Award terms

Application types allowed
NewResubmission The OER Glossary and the How to Apply - Application Guide provides details on these application types.
Award budget
Information
Project period
The total period of support is five years up to two years intramural, plus three years extramural). Other
Funds available and number of awards
The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Summarized from the NOFO text; the full NOFO governs eligibility, budget, and review.

Related NOFOs

  • Reissue of PAR-22-040.
  • Companion NOFOs: PAR-24-209.

Other open NOFOs for K22

Browse all open NIH NOFOs

About this page

GotGrant gathers the NOFO, its participation and change notices, and its NOSIs from the NIH Guide for Grants and Contracts, and counts funded projects from NIH RePORTER by the opportunity number each award was made under. Data refreshed October 16, 2026; the NIH Guide is the authoritative source. See our data methodology.

Find who wins under this NOFO